Leah Rosenbaum

These are Insider’s biggest healthcare stories for the week ending December 17.

These are Insider’s biggest healthcare stories for December 20.

Insider asked 18 investors which startups they think are ready to break out in 2022. Here are the 34 they named, from genomics to digital health.

Margo Georgiadis is focused on the intersection of healthcare and technology. “That revolution has really just started,” she said.

Dr. Ned Sharpless, the outgoing National Cancer Institute director, told Insider these were three of the cancer advances he’d keep an eye on.

Panelists at the 2022 BIO Convention shared tips on how companies can improve diversity and inclusion

Faeth Therapeutics raised $47 million to slow cancer-cell growth using specialized diets, one of the most exciting new areas of cancer research.

From 64x Bio to Faeth Therapeutics, here are the presentations that biotechs used to win over investors and raise millions to grow their companies.

The results from Guardant Health’s trial show that blood-based cancer screenings could work, but not all investors were impressed.

The results from Guardant Health’s trial show that blood-based cancer screenings could work, but not all investors were impressed.